Tumor aggression among hepatitis-C related hepatocellular carcinoma patients: an observational study regarding the impact of anti-HCV therapy

BACKGROUND: Hepatitis C virus (HCV) represents a major risk factor for hepatocellular carcinoma (HCC) development and anti-HCV therapy is a significant measure to reduce the incidence of HCC, however development of HCC in HCV treated patients is an emerging clinical problem which needs to be investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalid, Javeria, Umar, Mohammad, Ur-Rehman, Tofeeq, Ali, Mashhood, Khan, Gul Majid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251734/
https://www.ncbi.nlm.nih.gov/pubmed/32508980
http://dx.doi.org/10.1186/s13027-020-00300-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251734/
https://www.ncbi.nlm.nih.gov/pubmed/32508980
http://dx.doi.org/10.1186/s13027-020-00300-z

Ejemplares similares